Obermatt
See Similar Stocks →

Charming Medical

NAQ:MCTA · VGG205281089
Diversified Consumer ServicesSmall

360

22
Medium confidence — indicative
Profit price1
Owner Earnings Yield34
Dividend Yield1
Price/Sales1
EV / Gross Profit2
Price/Book1
Return on Capital100
Cash Return on Capital100
Return on Equity1
EBIT Margin73
Gross Profitability99
Cash Conversion11
Accruals3
Owner Earnings Margin80
Sales growth11
Profit Growth7
Long-Term EPS Growth17
Owner Earnings Growth39
Reinvestment66
Price momentum98
Debt load12
Refinancing24
Debt Payback100
Liquidity89
Analyst ratings—
Expectations trend—
Market mood6
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Charming Medical clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryHong Kong SAR China
IndustryDiversified Consumer Services
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2024
ISINVGG205281089
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
LifestyleNutraceuticalReproductive HealthWomen's HealthAllergyAlternative MedicineWellness and Recovery

Description

Charming Medical Limited, through its subsidiaries, principally engages in the provision of beauty, wellness and postpartum services in Hong Kong with a focus on utilizing traditional Chinese medicines approaches in addressing women’s health issues.…

Analysis

Hope premium

Charming Medical Limited is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is expensive. The owner-earnings multiple stands at 764.1×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is adequate. The company scores 12/20 on our value-creation score: creating some value.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

Similar Stocks

The companies this stock is ranked against.

Compare Charming Medical with its peers
d'Alba Global
KSC:483650
99
CountrySouth Korea
IndustryPersonal Products
SizeSmall
Full Stock Analysis →
Concorde International
NAQ:CIGL
13
CountrySingapore
IndustryCommercial Services & Supplies
SizeSmall
Full Stock Analysis →
Samsung Pharm
KSC:001360
—
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Prenetics Global
NMQ:PRE
52
CountryHong Kong SAR China
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Samil Pharmaceutical
KSC:000520
28
CountrySouth Korea
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Pyridam Farma
JKT:PYFA
3
CountrySingapore
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →